2021年
-
Osawa Y, Kawai H, Tsunoda T, Komatsu H, Okawara M, Tsutsui Y, Yoshida Y, Yoshikawa S, Mori T, Yamazoe T, Yoshio S, Oide T, Inui A, Kanto T.Cluster of Differentiation 44 Promotes Liver Fibrosis and Serves as a Biomarker in Congestive Hepatopathy.Hepatol Commun. 2021 Apr 8;5(8):1437-1447. doi: 10.1002/hep4.1721. eCollection 2021 Aug.
-
Yoshida Y, Yoshio S, Yamazoe T, Mori T, Tsustui Y, Kawai H, Yoshikawa S, Fukuhara T, Okamoto T, Ono Y, Takahashi Y, Hashida R, Kawaguchi T, Taketomi A, Kanto T.
Phenotypic Characterization by Single-Cell Mass Cytometry of Human Intrahepatic and Peripheral NK Cells in Patients with Hepatocellular Carcinoma.Cells. 2021 Jun 14;10(6):1495. doi: 10.3390/cells10061495.
-
Yoshio S, Shimagaki T, Hashida R, Kawaguchi T, Tsutsui Y, Sakamoto Y, Yoshida Y, Kawai H, Yoshikawa S, Yamazoe T, Mori T, Osawa Y, Itoh S, Fukai M, Yoshizumi T, Taketomi A, Mori M, Kanto T.
Myostatin as a fibroblast-activating factor impacts on postoperative outcome in patients with hepatocellular carcinoma.
Hepatol Res. 2021 Jul;51(7):803-812. doi: 10.1111/hepr.13667. Epub 2021 May 25.
-
Itakura J, Kurosaki M, Setoyama H, Simakami T, Oza N, Korenaga M, Tanaka M, Torimura T, Sakamoto N, Enomoto N, Ueno Y, Kawada N, Kaneko S, Nishiguchi S, Chayama K, Tanaka J, Izumi N, Kanto T.
Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitis.
J Gastroenterol. 2021 May;56(5):470-478. doi: 10.1007/s00535-021-01782-3. Epub 2021 Mar 31.
-
Sakamoto Y, Yoshio S, Doi H, Mori T, Matsuda M, Kawai H, Shimagaki T, Yoshikawa S, Aoki Y, Osawa Y, Yoshida Y, Arai T, Itokawa N, Atsukawa M, Ito T, Honda T, Mise Y, Ono Y, Takahashi Y, Saiura A, Taketomi A, Kanto T.
Increased Frequency of Dysfunctional Siglec-7-CD57+PD-1+ Natural Killer Cells in Patients With Non-alcoholic Fatty Liver Disease.
Front Immunol. 2021 Feb 22;12:603133. doi: 10.3389/fimmu.2021.603133. eCollection 2021.
-
Osawa Y, Yoshio S, Aoki Y, Korenaga M, Imamura M, Oide T, Okawara M, Kawai H, Tsutsui Y, Yoshida Y, Yoshikawa S, Mori T, Yamazoe T, Kanto T.
Blood angiopoietin-2 predicts liver angiogenesis and fibrosis in hepatitis C patients. BMC Gastroenterol. 2021 Feb 8;21(1):55. doi: 10.1186/s12876-021-01633-8.
-
Yoshio S, Kanto T.
Macrophages as a source of fibrosis biomarkers for non-alcoholic fatty liver disease. Immunol Med. 2021 Jan 14:1-26. doi: 10.1080/25785826.2020.1868664.
共著論文
-
Tsuchihashi J, Koya S, Hirota K, Koga N, Narao H, Tomita M, Kawaguchi T, Hashida R, Nakano D, Tsutsumi T, Yoshio S, Matsuse H, Sanada T, Notsumata K, Torimura T.
Effects of In-Hospital Exercise on Frailty in Patients with Hepatocellular Carcinoma. Cancers (Basel). 2021 Jan 7;13(2):194. doi: 10.3390/cancers13020194.
